Authors: POOLEWILSON P CLELAND J HUBBARD W SUTTON G PITTARD J OSBORNE C LONG C INGHAM S ROBINSON P BALL S HAMPTON J POULTER N MURRAY G TRAVILL C BAIN RJ BAKSI A BAXTER RH BEEN A BERKIN KE BLACKWOOD R BLANDFORD RL BOYLE RM BUCHALTER M CAMPBELL R CHALLENOR V CHEADLE B COATS A COLLINS P COWAN C CREAMER J DANCY CM DAVIES J DAVIES R EHSANULLIAH M ELDER A FOWLER JM FULCHER RA GHOSH MK GREENBAUM RA GREENWOOD TW GRIMMER SEM HARVEY J HELLER A HENDERSON AN HENDRA T HENDREY WG HOGAN J HOLLINRAKE K HOLT P HUTTON I JONES A JONES I LEVY R LEWIS P LEWIS R MCCULLOCH A MCMAHON DG MCMURRAY JJ MCNEIL GP MONDAL BK MORANT AJ MURPHY J MURRAY RG NORTHCOTE RJ PATTERSON D PEASTON MJT PETRI MP PIPPEN CAR PITTSCRICK J PURI RK RAJ MVJ RAO SK REID C REITH SBM RODGER JC ROZCOVEC A SETHI P SHAPIRO L SILAS J SKEHAN JD SMITH D SMITH RH TERRY G THOMAS P TIMMIS S WALLER LD WALTON S WHALE RJ WIJAYAWARDHANA UD WILSON JL

Citation: P. Poolewilson et al., CLINICAL OUTCOME WITH ENALAPRIL IN SYMPTOMATIC CHRONIC HEART-FAILURE - A DOSE COMPARISON, European heart journal, 19(3), 1998, pp. 481-489

Authors: CLELAND JGF HUBBARD WN PITTARD J POOLEWILSON PA SUTTON GC

Citation: Jgf. Cleland et al., ACE-INHIBITORS IN HEART-FAILURE - WHAT DOSE, Postgraduate medical journal, 71(832), 1995, pp. 65-66